Stockscreener 앱 받기
18.72
0.32%
0.06
시간 외 거래:
18.72
전일 마감가:
$18.66
열려 있는:
$18.69
하루 거래량:
57,456
Relative Volume:
1.00
시가총액:
$167.28M
수익:
$101.90M
순이익/손실:
$-6.41M
주가수익비율:
-4.3105
EPS:
-4.3429
순현금흐름:
$-889.00K
1주 성능:
-1.94%
1개월 성능:
-6.12%
6개월 성능:
-43.08%
1년 성능:
-45.97%
1일 변동 폭
$18.50
$19.00
1주일 범위
$18.50
$20.34
52주 변동 폭
$18.29
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
명칭
Sanara Medtech Inc
전화
817-529-2300
주소
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
18.72 | 166.74M | 101.90M | -6.41M | -889.00K | -4.3429 |
|
ISRG
Intuitive Surgical Inc
|
479.93 | 169.66B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.53 | 44.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.01 | 36.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.59 | 34.30B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.41 | 33.20B | 5.40B | 1.49B | 1.78B | 10.12 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2024-12-23 | 개시 | H.C. Wainwright | Buy |
| 2022-05-20 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-30 | 개시 | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc 주식(SMTI)의 최신 뉴스
Sanara MedTech (NASDAQ:SMTI) Trading Up 0.8%Here's What Happened - MarketBeat
Aug Selloffs: Can Sanara MedTech Inc maintain sales growth2026 Earnings Surprises & High Accuracy Trade Alerts - baoquankhu1.vn
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds - Orthopedics This Week
Sanara MedTech (SMTI) upgraded to strong buy: Here's what you should know - MSN
Sanara MedTech study shows cost savings with CellerateRX powder - Investing.com India
Sanara MedTech study shows cost savings with CellerateRX powder By Investing.com - Investing.com South Africa
Sanara MedTech Inc. Announces Publication of Peer-Reviewed - GlobeNewswire
Sanara MedTech (SMTI) Study Highlights Cost-Effectiveness of Cel - GuruFocus
Spine surgery wounds: CellerateRX study finds $3,852 saved per patient - Stock Titan
Sanara MedTech (SMTI) CEO has shares withheld to cover tax on RSU vesting - Stock Titan
(SMTI) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Sanara MedTech (SMTI) CEO corrects Form 4 to 414 tax-withheld shares - Stock Titan
Merger Talk: Can Sanara MedTech Inc navigate macro headwindsWeekly Investment Summary & Daily Momentum Trading Reports - baoquankhu1.vn
Valuation Update: Is Sanara MedTech Inc undervalued by DCF analysisRecession Risk & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - marketscreener.com
Sanara MedTech Unveils 2026 Strategy in Investor Presentation - The Globe and Mail
Sanara MedTech (SMTI) CEO has 491 shares withheld to cover tax on vesting - Stock Titan
Sanara MedTech (NASDAQ: SMTI) furnishes 2026 outlook deck - Stock Titan
SMTI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SMTI Should I Buy - Intellectia AI
SMTI PE Ratio & Valuation, Is SMTI Overvalued - Intellectia AI
Sanara MedTech (SMTI) COO has shares withheld to cover taxes - Stock Titan
Sanara MedTech (SMTI) CFO uses 437 shares to cover tax withholding - Stock Titan
Sanara MedTech (SMTI) Controller has 149 shares withheld for taxes - Stock Titan
(SMTI) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Reviewing Koninklijke Philips (NYSE:PHG) and Sanara MedTech (NASDAQ:SMTI) - Defense World
Patterns Watch: Whats next for Sanara MedTech Inc stockMarket Weekly Review & Weekly High Momentum Picks - baoquankhu1.vn
SMTI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sanara MedTech Inc. (SMTI) Stock Analysis: Unpacking a 103.56% Potential Upside for Investors - DirectorsTalk Interviews
Sanara MedTech (NASDAQ:SMTI) Shares Up 2.9%Time to Buy? - MarketBeat
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd - Bitget
Sanara MedTech Inc. to Present at TD Cowen 46th Annual Health Care Conference - Quiver Quantitative
Why Sanara MedTech Inc. stock is a must watch in 2025July 2025 Trends & Daily Stock Trend Reports - mfd.ru
(SMTI) Risk Channels and Responsive Allocation - Stock Traders Daily
What is Sanara MedTech Inc. s 5 year growth outlookShare Buyback & Weekly Stock Performance Updates - mfd.ru
Will Sanara MedTech Inc. stock see insider buyingIPO Watch & Stepwise Entry/Exit Trade Alerts - mfd.ru
Is Sanara MedTech Inc. undervalued by DCF analysisRate Cut & Real-Time Price Movement Reports - mfd.ru
Shareholders in Sanara MedTech (NASDAQ:SMTI) are in the red if they invested three years ago - Yahoo Finance
Can Sanara MedTech Inc. deliver consistent dividends2025 Market WrapUp & Reliable Entry Point Trade Alerts - mfd.ru
What margin trends mean for Sanara MedTech Inc. stockTrade Entry Report & Weekly Stock Performance Updates - mfd.ru
Will Sanara MedTech Inc. stock deliver shareholder valueWeekly Stock Recap & Long-Term Growth Stock Strategies - mfd.ru
Sanara Medtech's Growth Trajectory Gains Momentum Amid Strategic Shift () - aktiencheck.de
(SMTI) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Sanara MedTech’s Stock Under the Microscope: Niche Wound-Care Player Tests Investor Patience - AD HOC NEWS
Stop Loss: Is FNGS in a consolidation phasePortfolio Risk Report & Free Community Consensus Stock Picks - baoquankhu1.vn
HC Wainwright Predicts Weaker Earnings for Sanara MedTech - MarketBeat
Analysts Issue Forecasts for Sanara MedTech FY2025 Earnings - Defense World
Sanara MedTech FY2025 EPS Forecast Boosted by HC Wainwright - MarketBeat
SMTI Latest Analyst Rating Update: HC Wainwright & Co. Reiterates Buy | SMTI Stock News - GuruFocus
Sanara MedTech (NASDAQ:SMTI) Receives “Buy” Rating from HC Wainwright - Defense World
HC Wainwright Reiterates Buy Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Sanara Medtech Inc (SMTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
0.65%
자본화:
|
볼륨(24시간):